Aurobindo gets FDA approval for nifedipine extended-release tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application nifedipine extended-release tablets USP, 30mg, 60mg, and 90mg. Aurobindo Pharma’s nifedipine extended-release tablets USP, 30mg, 60mg, and 90mg, are an AB-rated generic equivalent to the reference listed drug (RLD), ADALAT CC of
